Memorial Sloan Kettering Cancer Center
πΊπΈUnited States
- Country
- πΊπΈUnited States
- Ownership
- Private
- Established
- 1884-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.mskcc.org
Differential Risks for Melanoma: p16 and DNA Repair
Completed
- Conditions
- Skin MelanomaMelanoma
- Interventions
- Other: self-administered questionnaire and blood drawOther: health questionnaire, blood draw and skin exam
- First Posted Date
- 2008-02-14
- Last Posted Date
- 2011-04-20
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 323
- Registration Number
- NCT00615095
- Locations
- πΊπΈ
Memorial Sloan-Kettering Cancer Center, New York, New York, United States
Accuracy of the D-Dimer Assay for the Exclusion of Pulmonary Embolism in a High Risk Oncologic Population
Completed
- Conditions
- CancerPulmonary Embolism
- Interventions
- Procedure: CT pulmonary angiogram and d-dimer draw
- First Posted Date
- 2008-02-14
- Last Posted Date
- 2012-01-09
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 213
- Registration Number
- NCT00615147
- Locations
- πΊπΈ
Memorial Sloan-Kettering Cancer Center, New York, New York, United States
Adjuvant Docetaxel Plus Gemcitabine in Patients With Completely Resected Leiomyosarcoma (LMS) of the Uterus
Not Applicable
Completed
- Conditions
- Uterine LeiomyosarcomaUterine Cancer
- Interventions
- First Posted Date
- 2008-02-13
- Last Posted Date
- 2015-12-22
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 25
- Registration Number
- NCT00614835
- Locations
- πΊπΈ
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Biodistribution and Dosimetry of Serial PET Imaging With Ga-68 Labeled F(ab') 2- Trastuzumab
Phase 1
Completed
- Conditions
- Solid Tumors
- Interventions
- Radiation: PET Imaging with Ga-68 Labeled F(ab') 2- Trastuzumab
- First Posted Date
- 2008-02-13
- Last Posted Date
- 2020-10-26
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 17
- Registration Number
- NCT00613847
- Locations
- πΊπΈ
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Use of Screening Colonoscopy Among Minority Women and Men
Completed
- Conditions
- Colorectal Screening
- Interventions
- Procedure: Colonoscopy and Questionnaire
- First Posted Date
- 2008-02-13
- Last Posted Date
- 2009-01-15
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 611
- Registration Number
- NCT00613873
- Locations
- πΊπΈ
Breast Examination Center of Harlem, New York, New York, United States
πΊπΈMemorial Sloan Kettering Cancer Center, New York, New York, United States
3-D Reconstruction of CT Scan Images in the Evaluation of Non-Specific Pulmonary Nodules
Completed
- Conditions
- Lung NodulesUndiagnosed Pulmonary Nodules
- Interventions
- Procedure: CT Scan
- First Posted Date
- 2008-02-12
- Last Posted Date
- 2023-09-13
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 19
- Registration Number
- NCT00613041
- Locations
- πΊπΈ
Memorial Sloan Kettering Cancer Center, New York, New York, United States
DNA Repair and Genetic Susceptibility to Lung Cancer
Completed
- Conditions
- Second Primary Lung CancerLung CancerSingle Primary Lung Cancer
- Interventions
- Other: Blood draw and Questionnaires
- First Posted Date
- 2008-02-11
- Last Posted Date
- 2023-03-29
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 218
- Registration Number
- NCT00611598
- Locations
- πΊπΈ
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Feasibility Evaluation of Magnetic Resonance Imaging and Positron Emission Tomography for Bladder Cancer Diagnosis and Staging
Completed
- Conditions
- Transitional Cell CarcinomaBladder Cancer
- Interventions
- Procedure: MRI and PET scanning procedures
- First Posted Date
- 2008-02-11
- Last Posted Date
- 2015-12-18
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 26
- Registration Number
- NCT00612326
- Locations
- πΊπΈ
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Environmental Pollutants and the Risk of Soft Tissue Sarcoma: A Pilot Study
Completed
- Conditions
- Soft Tissue Sarcoma
- First Posted Date
- 2008-02-08
- Last Posted Date
- 2011-01-20
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 56
- Registration Number
- NCT00611078
- Locations
- πΊπΈ
Memorial Sloan-Kettering Cancer Center, New York, New York, United States
LSA4 Protocol for the Treatment of Advanced Pediatric and Adolescent Non-Hodgkins Lymphoma
Phase 2
Completed
- Conditions
- Non-Hodgkin's Lymphoma
- Interventions
- Drug: LSA4, Cyclophosphamide, Methotrexate, Daunomycin, L-asparaginase, BCNU
- First Posted Date
- 2008-02-08
- Last Posted Date
- 2023-09-28
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 17
- Registration Number
- NCT00610883
- Locations
- πΊπΈ
Memorial Sloan-Kettering Cancer Center, New York, New York, United States